JP2881333B2 - Whitening cosmetics - Google Patents
Whitening cosmeticsInfo
- Publication number
- JP2881333B2 JP2881333B2 JP2131988A JP13198890A JP2881333B2 JP 2881333 B2 JP2881333 B2 JP 2881333B2 JP 2131988 A JP2131988 A JP 2131988A JP 13198890 A JP13198890 A JP 13198890A JP 2881333 B2 JP2881333 B2 JP 2881333B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- esters
- salts
- vitamin
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title description 23
- 230000002087 whitening effect Effects 0.000 title description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 150000003839 salts Chemical class 0.000 claims description 29
- 150000002148 esters Chemical class 0.000 claims description 26
- 235000003956 Luffa Nutrition 0.000 claims description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 210000002826 placenta Anatomy 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 7
- 229960004488 linolenic acid Drugs 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000020778 linoleic acid Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 244000050983 Luffa operculata Species 0.000 claims 1
- 241000219138 Luffa Species 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 244000302544 Luffa aegyptiaca Species 0.000 description 10
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 10
- 208000012641 Pigmentation disease Diseases 0.000 description 10
- 230000019612 pigmentation Effects 0.000 description 10
- -1 sodium linoleate Chemical compound 0.000 description 9
- 239000008213 purified water Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 2
- 229940031016 ethyl linoleate Drugs 0.000 description 2
- 229940007062 eucalyptus extract Drugs 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- SOQQSPURSLWWMI-UHFFFAOYSA-N 1,3-thiazole-4-carbothioamide Chemical compound NC(=S)C1=CSC=N1 SOQQSPURSLWWMI-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- KEFXZUBYCDCSNP-UHFFFAOYSA-N [Th].C(CC(O)(C(=O)O)CC(=O)O)(=O)O Chemical compound [Th].C(CC(O)(C(=O)O)CC(=O)O)(=O)O KEFXZUBYCDCSNP-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- MJLYTDAIYLGSRZ-ORZIMQNZSA-N gamma-Linolenic acid ethyl ester Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(=O)OCC MJLYTDAIYLGSRZ-ORZIMQNZSA-N 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 description 1
- UNZSHUCNBUBSGW-IFNWOZJISA-M sodium;(9z,12z,15z)-octadeca-9,12,15-trienoate Chemical compound [Na+].CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O UNZSHUCNBUBSGW-IFNWOZJISA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 150000002266 vitamin A derivatives Chemical class 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、日焼け(紫外線)による皮膚の黒化あるい
はシミ、ソバカスなど皮膚の色素沈着を消失もしくは淡
色化し、あるいはこれらを予防する美白化粧料に関す
る。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a whitening cosmetic for preventing or preventing blackening of the skin due to sunburn (ultraviolet rays) or pigmentation of the skin such as spots and freckles. About.
[従来の技術および課題] 従来、美白化粧料組成物としてはビタミンCおよびそ
の誘導体、あるいは還元剤、プラセンタエキスなどチロ
シンからメラニンを生成するチロシナーゼの活性阻害剤
を配合したものが知られている。[Related Art and Problems] Conventionally, as a whitening cosmetic composition, a composition containing a tyrosinase activity inhibitor that produces melanin from tyrosine, such as vitamin C and its derivatives, a reducing agent, and a placenta extract, is known.
例えば、特開昭61−194008号公報には、L−アスコル
ビン酸(ビタミンC)およびそのエステルから選ばれた
一種または二種以上と、ヘチマの液汁とを含有する化粧
料について記載されている。また、特開昭57−77610号
公報には、ウリ科植物のメラニン産生抑制作用について
記載されている。For example, Japanese Patent Application Laid-Open No. 61-194008 describes a cosmetic containing one or more selected from L-ascorbic acid (vitamin C) and its ester, and a luffa sap. JP-A-57-77610 describes a melanin production inhibitory action of cucurbits.
しかしながら、これら従来の美白化粧料は培養細胞に
よるin vitroの実験ではメラニン産生抑制作用などを示
すものの、実際の皮膚に適用した場合、充分な色素沈着
の消失もしくは淡色化などの効果は得られず、また皮膚
に対する刺激がある等の副作用があった。However, these conventional whitening cosmetics show melanin production inhibitory effects in in vitro experiments using cultured cells, but when applied to actual skin, sufficient effects such as disappearance of pigmentation or lightening cannot be obtained. Side effects such as irritation to the skin.
本発明の目的は、優れた美白効果を有し、かつ皮膚に
対する刺激のない化粧料を提供することにある。An object of the present invention is to provide a cosmetic having an excellent whitening effect and having no irritation to the skin.
[課題を解決するための手段] 本発明者らは、優れた美白化粧料を得るべく鋭意研究
を重ねた結果、ヘチマ水にプラセンタンエキス、リノー
ル酸、ビタミンAなどの特定成分を加えることにより、
そのチロシナーゼ活性阻害作用が強化されると共に、皮
膚刺激の少ない化粧料が得られることを知り、本発明を
完成するに至った。[Means for Solving the Problems] The present inventors have conducted intensive studies to obtain an excellent whitening cosmetic, and as a result, by adding specific components such as placentan extract, linoleic acid, and vitamin A to luffa water. ,
The present inventors have found that the tyrosinase activity inhibitory action is enhanced and that cosmetics with less skin irritation can be obtained, and have completed the present invention.
すなわち、本発明は、ヘチマ水と;プラセンタエキ
ス、リノール酸およびその塩またはエステル、リノレン
酸およびその塩またはエステル、トウキエキス、エイコ
サペンタエン酸およびその塩またはそのエステル、ヘキ
サドコサエン酸およびその塩またはエステル、パントテ
ン酸およびその塩またはエステル、ビタミンA、ビタミ
ンB、ビタミンEおよびその塩またはエステル、感光素
201号並びに感光素401号より選ばれた少なくとも1種の
成分とを配合したことを特徴とする美白化粧料を提供す
るものである。That is, the present invention relates to the use of luffa water; placenta extract, linoleic acid and its salts or esters, linolenic acid and its salts or esters, eucalyptus extract, eicosapentaenoic acid and its salts or esters, hexadocosaenoic acid and its salts or Ester, pantothenic acid and its salt or ester, vitamin A, vitamin B, vitamin E and its salt or ester, photosensitizer
An object of the present invention is to provide a whitening cosmetic comprising at least one component selected from No. 201 and No. 401.
本発明で使用する「ヘチマ」はウリ科(Cucurbitacea
e)のLuffa cylindrica Roemである。本発明で使用する
ヘチマ水は、ヘチマの果実または茎から滲出する液汁で
あり、公知の方法により採取することができる。"Loofah" used in the present invention is Cucurbitacea
e) Luffa cylindrica Roem. The luffa water used in the present invention is a sap that exudes from a luffa fruit or stem, and can be collected by a known method.
採取したヘチマ水はそのまま放置すると、腐敗、菌の
繁殖等が生ずる。このため採取したヘチマ水にエタノー
ル、パラオキシ安息香酸エステルまたはその塩、安息香
酸またはその塩、サリチル酸またはその塩、ソルビン酸
またはその塩、デヒドロ酢酸またはその塩、イソプロピ
ルメチルフェノール、オルトフェニルフェノール、クレ
ゾール、フェノキシエタノールなどの防腐剤を適宜添加
することが望ましい。If the collected loofah water is left as it is, decay, propagation of bacteria, etc. occur. For this purpose, the collected luffa water contains ethanol, paraoxybenzoic acid ester or its salt, benzoic acid or its salt, salicylic acid or its salt, sorbic acid or its salt, dehydroacetic acid or its salt, isopropylmethylphenol, orthophenylphenol, cresol, It is desirable to appropriately add a preservative such as phenoxyethanol.
本発明の化粧料中におけるヘチマ水の配合量は、3〜
99重量%、好ましくは、5〜95重量%、さらに好ましく
は5〜90重量%である。The amount of luffa water in the cosmetic of the present invention is 3 to
It is 99% by weight, preferably 5 to 95% by weight, more preferably 5 to 90% by weight.
ヘチマ水の配合量が3%未満であると皮膚の色素沈着
の消失、もしくは淡色化の効果が低く、一方99%を越え
ると防腐剤、安定剤、保存剤の配合が制限されヘチマ水
の保存安定性が低下し好ましくない。If the amount of loofah water is less than 3%, the pigmentation of the skin disappears or the effect of lightening is low, while if it exceeds 99%, the formulation of preservatives, stabilizers, and preservatives is limited, and the loofah water is preserved. It is not preferable because the stability decreases.
本発明化粧料においてヘチマ水と共に配合される成分
としては、プラセンタエキス、リノール酸およびその塩
またはエステル、リノレン酸およびその塩またはエステ
ル、トウキエキス、エイコサペンタエン酸およびその塩
またはエステル、ヘキサドコサエン酸およびその塩また
はエステル、パントテン酸およびその塩またはエステ
ル、ビタミンA、ビタミンB、ビタミンEおよびその塩
またはエステル、感光素201号、感光素401号などが挙げ
られる。これらは単独でまた併用して配合されてよい。Ingredients to be blended with luffa water in the cosmetic of the present invention include placenta extract, linoleic acid and its salts or esters, linolenic acid and its salts or esters, eucalyptus extract, eicosapentaenoic acid and its salts or esters, hexadocosaenoic acid And salts or esters thereof, pantothenic acid and salts or esters thereof, vitamin A, vitamin B, vitamin E and salts or esters thereof, and Photosensitizer No. 201 and Photosensitizer No. 401. These may be used alone or in combination.
リノール酸の誘導体としては、リノール酸カリウム、
リノール酸ナトリウムなどの塩、およびリノール酸メチ
ル、リノール酸エチル、リノール酸イソプロピルなどの
エステルが挙げられる。Derivatives of linoleic acid include potassium linoleate,
Salts such as sodium linoleate, and esters such as methyl linoleate, ethyl linoleate, isopropyl linoleate.
リノレン酸としては、α−リノレン酸、γ−リノレン
酸が挙げられ、その誘導体としてはα−リノレン酸ナト
リウムなどの塩、γ−リノレン酸エチルなどのエステル
が挙げられる。Linolenic acid includes α-linolenic acid and γ-linolenic acid, and derivatives thereof include salts such as sodium α-linolenate and esters such as ethyl γ-linolenate.
パントテン酸の誘導体としてはパントテン酸カルシウ
ム、パントテン酸ナトリウムなどの塩、パントテニルエ
チルエーテル、アセチルパントテニルエチルエーテルな
どが挙げられる。Derivatives of pantothenic acid include salts such as calcium pantothenate and sodium pantothenate, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether and the like.
ビタミンA(レチノール)の誘導体としては、酢酸レ
チノール、パルミチン酸レチノールなどのエステル、お
よびデヒドロレチノールなどが挙げられる。Derivatives of vitamin A (retinol) include esters such as retinol acetate, retinol palmitate, and dehydroretinol.
ビタミンE(DL−α−トコフェロール)の誘導体とし
ては、酢酸dl−α−トコフェロール、リノール酸dl−α
−トコフェロール、リノレン酸dl−α−トコフェロール
などのエステルが挙げられる。Derivatives of vitamin E (DL-α-tocopherol) include dl-α-tocopherol acetate, dl-α linoleate
Esters such as tocopherol and linolenic acid dl-α-tocopherol.
従来これら各成分とヘチマ水との併用により、皮膚に
対する美白効果が増強されることについては知られてい
ない。Conventionally, it has not been known that the combination use of these components with luffa water enhances the whitening effect on the skin.
これら各成分とヘチマ水とを配合した化粧料について
その色素沈着抑制作用を評価した結果をつぎに示す。The results of evaluating the pigmentation-inhibiting action of a cosmetic containing these components and luffa water are shown below.
試験方法:English系茶色モルモットの背部を剃毛し、
紫外線(UVB強度:1J/cm2)を照射した。この操作を3日
間繰り返し、その間後記第1表に示す検体(試験例1〜
24)を紫外線照射部に塗布した。10日間放置後、以下に
示す判定基準に従い、色素沈着度を肉眼判定した。Test method: Shaving the back of English brown guinea pig,
Ultraviolet rays (UVB intensity: 1 J / cm 2 ) were irradiated. This operation was repeated for three days, during which the samples shown in Table 1 below (Test Examples 1 to 5)
24) was applied to an ultraviolet irradiation part. After standing for 10 days, the degree of pigmentation was visually determined according to the following criteria.
−:色素沈着なし ±:わずかな色素沈着 +:中等度の色素沈着 ++:強度の色素沈着 結果を第1表に示す。 -: No pigmentation ±: Slight pigmentation +: Moderate pigmentation ++: Intense pigmentation The results are shown in Table 1.
第1表より明らかなごとく、ヘチマ水とプラセンタエ
キスなどの成分とを併用した場合は、他の場合に比べて
色素沈着の顕著な淡色化が認められる。 As is clear from Table 1, when luffa water and a component such as placenta extract are used in combination, remarkable lightening of pigmentation is observed as compared with the other cases.
これらヘチマ水とともに本発明化粧料に配合される成
分の配合量は、各成分に応じて適宜調整される。プラセ
ンタエキス;リノール酸、リノレン酸、エイコサペンタ
エン酸、ヘキサドコサエン酸およびこれらの塩またはエ
ステルは、いずれも化粧料全量に対して0.05〜50重量
%、好ましくは0.1〜10重量%配合する。トウキエキ
ス、コウジ酸およびその塩またはエステルは、いずれも
0.05〜10重量%、好ましくは0.1〜5重量%配合する。
また、パントテン酸およびその塩またはエステルは、0.
01〜10重量%、好ましくは0.1〜10重量%配合する。ビ
タミンA、ビタミンB、ビタミンEは、0.001〜10重量
%、好ましくは0.01〜5重量%配合する。感光素201
号、感光素401号は、0.0001〜0.5重量%、好ましくは0.
001〜0.1重量%配合する。The amounts of the components to be added to the cosmetic of the present invention together with the luffa water are appropriately adjusted according to each component. Placenta extract; linoleic acid, linolenic acid, eicosapentaenoic acid, hexadocosaenoic acid, and salts or esters thereof are all incorporated at 0.05 to 50% by weight, preferably 0.1 to 10% by weight, based on the total amount of the cosmetic. Touki extract, kojic acid and its salts or esters,
0.05 to 10% by weight, preferably 0.1 to 5% by weight.
In addition, pantothenic acid and its salts or esters are 0.
01 to 10% by weight, preferably 0.1 to 10% by weight. Vitamin A, Vitamin B and Vitamin E are added in an amount of 0.001 to 10% by weight, preferably 0.01 to 5% by weight. Photosensitive element 201
No. 401, 0.0001 to 0.5% by weight, preferably 0.1% by weight.
001-0.1% by weight is blended.
これらヘチマ水と共に本発明化粧料に配合される各成
分の量が前記範囲よりも少ないと充分な美白効果が得ら
れず、一方、上限を超えると皮膚刺激を生ずる。If the amount of each component blended in the cosmetic of the present invention together with the luffa water is less than the above range, a sufficient whitening effect cannot be obtained, while if it exceeds the upper limit, skin irritation occurs.
本発明の美白化粧料は、公知の方法によりクルーム、
乳液、化粧水、パック、ファンデーション、エッセンス
などの化粧料として調製される。また、本発明の化粧料
には、その種類に応じ性能を損なわない範囲において、
適宜公知の成分を配合することができる。すなわち、本
発明の化粧料には上記必須成分の他に、通常化粧料に用
いられ配合される成分、例えば、油分、紫外線吸収剤、
酸化防止剤、界面活性剤、防腐剤、香料、水、アルコー
ル、増粘剤、色素等を必要に応じて適宜配合することが
できる。The whitening cosmetic of the present invention is a cloam by a known method,
It is prepared as cosmetics such as emulsions, lotions, packs, foundations and essences. In addition, the cosmetic of the present invention, within a range that does not impair the performance according to the type,
Known components can be appropriately blended. That is, the cosmetic of the present invention, in addition to the above essential components, components usually used and blended in cosmetics, for example, oil, ultraviolet absorber,
Antioxidants, surfactants, preservatives, fragrances, water, alcohols, thickeners, dyes, and the like can be appropriately added as necessary.
[実施例] つぎに本発明を実施例にもとづきさらに具体的に説明
する。配合量は全て重量%である。EXAMPLES Next, the present invention will be described more specifically based on examples. All amounts are by weight.
実施例1(クリーム) 成 分 配合量 モノステアリン酸ソルビタン 2.0 自己乳化型モノステアリング酸グリセリン 3.0 ミリスチン酸セチル 1.5 ミリスチン酸イソプロピル 3.0 セタノール 2.0 ステアリン酸 2.0 流動パラフィン 7.0 トリエタノールアミン 0.4 パラオキシ安息香酸メチル 0.2 パラオキシ安息香酸ブチル 0.1 1,3−ブチレングリコール 6.0 ヘチマ水 50.0 エタノール 2.0 プラセンタエキス 5.0 トウキエキス 1.0 香料 0.2 精製水 残部 計 100 実施例2(乳液) 成 分 配合量 自己乳化型モノステアリン酸グリセリン 3.0 ステアリン酸 1.5 セタノール 1.0 流動パラフィン 5.0 パルミチン酸イソプロピル 2.0 トリエタノールアミン 0.3 ポリオキシエチレンモノステアリン酸 ソルビタン(20E.O.) 1.0 パラオキシ安息香酸エチル 0.3 プロピレングリコール 5.0 ヘチマ水 60.0 カルボキシビニルポリマー 0.3 リノール酸 3.0 感光素401号 0.002 香料 0.15 精製水 残部 計 100 実施例3(化粧水) 成 分 配合量 ポリオキシエチレン硬化ヒマシ油 (40E.O.) 0.7 エタノール 12.0 香料 0.1 感光素201号 0.002 1,3−ブチレングリコール 5.0 クエン酸 0.2 クエン酸ナトリウム 0.3 d1−ピロリドンカルボン酸ナトリウム 1.0 ヘチマ水 70.0 プラセンタエキス 5.0 精製水 残部 計 100 実施例4(パック) 成 分 配合量 ポリビニルアルコール 15.0 エタノール 14.0 プロピレングリコール 4.0 ポリオキシエチレン(20.E.O.) セチルエーテル 0.6 香料 0.15 ヘチマ水 50.0 コウジ酸 0.5 酸化チタン 5.0 タルク 2.0 リノール酸エチル 1.0 精製水 残部 計 100 実施例5(化粧用エッセンス) 成 分 配合量 エイコサペンタエン酸エチル 1.0 グリセリン 15.0 エタノール 8.0 ポリオキシエチレン硬化ヒマシ油 (60E.O) 0.9 パラオキシ安息香酸エチル 0.1 ヘチマ水 65.0 香料 0.1 カルボキシビニルポリマー 0.6 トリエタノールアミン 0.3 精製水 残部 計 100 実施例6(パウダー 成 分 配合量 ヘキサドコサエン酸 2.0 デキストリン 90.0 タルク 2.0 ステアリン酸デカグリセリル 1.0 ヘチマ水 5.0 実施例7(パック) 成 分 配合量 パントテン酸カルシウム 2.0 ヘチマ水 45.0 酢酸ビニル・スチレン共重合体 10.0 ポリビニルアルコール 10.0 ソルビット 5.0 酸化チタン 6.0 カオリン 5.0 エタノール 8.0 香料 0.2 パラオキシ安息香酸メチル 0.1 精製水 残部 計 100 実施例8(乳液) 成 分 配合量 酢酸レチノール 0.02 ヘチマ水 70.0 流動パラフィン 5.0 ワセリン 2.0 ミツロウ 2.0 セスキオレイン酸ソルビタン 2.0 ポリオキシエチレン オレイルエーテル(20E.O) 2.5 パラオキシ安息香酸エチル 0.3 プロピレングリコール 5.0 カルボキシビニルポリマー 0.5 水酸化カリウム 0.3 香料 0.1 精製水 残部 計 100 実施例9(クリーム) 成 分 配合量 リノール酸トコフェロール 1.0 サラシミツロウ 4.0 セタノール 2.0 ステアリン酸 2.0 ミリスチン酸イソプロピル 5.0 ラノリン 2.0 流動パラフィン 6.0 自己乳化型モノステアリン酸グリセリン 3.0 モノステアリン酸ポリオキシエチレン ソルビタン(20E.O) 1.8 パラオキシ安息香酸プロピル 0.1 パラオキシ安息香酸メチル 0.3 プロピレングリコール 5.0 ヘチマ水 50.0 香料 0.2 精製水 残部 計 100 実施例10(化粧水) 成 分 配合量 塩酸ピリドキシン 0.1 グリセリン 4.0 エタノール 10.0 ヘチマ水 50.0 ポリオキシエチレン硬化ヒマシ油 (40E.O) 0.5 パラオキシ安息香酸メチル 0.05 クエン酸 0.05 クエン酸ナトリウム 0.07 dl−ピロリドンカルバン酸ナトリウム 1.0 精製水 残部 計 100 実施例1〜10の化粧料は、いずれも優れた美白効果を
有していた。Example 1 (Cream) Ingredient Ingredients Sorbitan monostearate 2.0 Self-emulsifying glycerin monosteering acid 3.0 Cetyl myristate 1.5 Isopropyl myristate 3.0 Cetanol 2.0 Stearic acid 2.0 Liquid paraffin 7.0 Triethanolamine 0.4 Methyl paraoxybenzoate 0.2 Paraoxybenzoate Butyl acid 0.1 1,3-butylene glycol 6.0 Loofah water 50.0 Ethanol 2.0 Placenta extract 5.0 Touki extract 1.0 Perfume 0.2 Purified water balance Total 100 Example 2 (Emulsion) Ingredient Content Self-emulsifying glyceryl monostearate 3.0 Stearic acid 1.5 Cetanol 1.0 Liquid paraffin 5.0 Isopropyl palmitate 2.0 Triethanolamine 0.3 Polyoxyethylene monostearate sorbitan (20E.O.) 1.0 Ethyl paraoxybenzoate 0.3 Propylene glycol 5.0 Loofah water 60 .0 Carboxyvinyl polymer 0.3 Linoleic acid 3.0 Photosensitizer No. 401 0.002 Perfume 0.15 Purified water Balance 100 Total Example 3 (Lotion) Ingredients Polyoxyethylene hydrogenated castor oil (40E.O.) 0.7 Ethanol 12.0 Perfume 0.1 Photosensitivity Element 201 0.002 1,3-butylene glycol 5.0 citric acid 0.2 sodium citrate 0.3 d1-pyrrolidone carboxylate 1.0 luffa water 70.0 placenta extract 5.0 purified water balance total 100 Example 4 (pack) Ingredient Content Polyvinyl alcohol 15.0 Ethanol 14.0 Propylene glycol 4.0 Polyoxyethylene (20.EO) Cetyl ether 0.6 Fragrance 0.15 Loofah water 50.0 Kojic acid 0.5 Titanium oxide 5.0 Talc 2.0 Ethyl linoleate 1.0 Purified water Balance Total 100 Example 5 (cosmetic essence) Ethyl icosapentaenoate 1.0 Glycerin 15.0 Ethanol 8.0 Polyoxy Tylene-hardened castor oil (60E.O) 0.9 Ethyl paraoxybenzoate 0.1 Loofah water 65.0 Fragrance 0.1 Carboxyvinyl polymer 0.6 Triethanolamine 0.3 Purified water Balance Total 100 Example 6 (Powder component blending amount Hexadocosaenoic acid 2.0 Dextrin 90.0 talc 2.0 Decaglyceryl stearate 1.0 Luffa water 5.0 Example 7 (pack) Ingredients Compounding amount Calcium pantothenate 2.0 Luffa water 45.0 Vinyl acetate / styrene copolymer 10.0 Polyvinyl alcohol 10.0 Sorbit 5.0 Titanium oxide 6.0 Kaolin 5.0 Ethanol 8.0 Perfume 0.2 Paraoxybenzoate Example 8 (Emulsion) Ingredients Retinol acetate 0.02 Luffa water 70.0 Liquid paraffin 5.0 Vaseline 2.0 Beeswax 2.0 Sorbitan sesquioleate 2.0 Polyoxyethylene oleyl ether (20E.O) 2.5 Para Ethyl oxybenzoate 0.3 Propylene glycol 5.0 Carboxyvinyl polymer 0.5 Potassium hydroxide 0.3 Perfume 0.1 Purified water Balance Total 100 Example 9 (Cream) Ingredient Ingredient Tocopherol linoleate 1.0 Salami beeswax 4.0 Cetanol 2.0 Stearic acid 2.0 Isopropyl myristate 5.0 Lanolin 2.0 Liquid paraffin 6.0 Self-emulsifying glyceryl monostearate 3.0 Polyoxyethylene sorbitan monostearate (20E.O) 1.8 Propyl parahydroxybenzoate 0.1 Methyl paraoxybenzoate 0.3 Propylene glycol 5.0 Loofah water 50.0 Perfume 0.2 Purified water Remaining 100 Total Examples 10 (Lotion) Ingredients Compounding amount Pyridoxine hydrochloride 0.1 Glycerin 4.0 Ethanol 10.0 Luffa water 50.0 Polyoxyethylene hydrogenated castor oil (40E.O) 0.5 Methyl parahydroxybenzoate 0.05 Citric acid 0.05 Citric acid Thorium 0.07 dl-pyrrolidone Calvin sodium 1.0 Purified water balance Total 100 cosmetics of Examples 1 to 10 are all had excellent whitening effect.
[発明の効果] 本発明の美白化粧料は優れた美白効果を有し、かつ皮
膚に対する刺激がない。[Effect of the Invention] The whitening cosmetic of the present invention has an excellent whitening effect and has no irritation to the skin.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 - 7/50 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 6 , DB name) A61K 7/00-7/50
Claims (1)
酸およびその塩またはエステル、リノレン酸およびその
塩またはエステル、トウキエキス、エイコサペンタエン
酸およびその塩またはエステル、ヘキサドコサエン酸お
よびその塩またはエステル、パントテン酸およびその塩
またはエステル、ビタミンA、ビタミンB、ビタミンE
およびその塩またはエステル、感光素201号並びに感光
素401号より選ばれた少なくとも1種の成分とを配合し
たことを特徴とする美白化粧料。1. With luffa water; placenta extract, linoleic acid and its salts or esters, linolenic acid and its salts or esters, touki extract, eicosapentaenoic acid and its salts or esters, hexadocosaenoic acid and its salts or esters, Pantothenic acid and its salts or esters, vitamin A, vitamin B, vitamin E
And a salt or ester thereof, and at least one component selected from photosensitive elements 201 and 401.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2131988A JP2881333B2 (en) | 1990-05-22 | 1990-05-22 | Whitening cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2131988A JP2881333B2 (en) | 1990-05-22 | 1990-05-22 | Whitening cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0426610A JPH0426610A (en) | 1992-01-29 |
| JP2881333B2 true JP2881333B2 (en) | 1999-04-12 |
Family
ID=15070932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2131988A Expired - Fee Related JP2881333B2 (en) | 1990-05-22 | 1990-05-22 | Whitening cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2881333B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101256180B1 (en) * | 2011-07-25 | 2013-04-19 | 동의대학교 산학협력단 | Cosmetic composition comprising extract of thin film outer cover of Luffa Roemer seed for skin whitening |
| KR20210023155A (en) * | 2019-08-22 | 2021-03-04 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5759524A (en) * | 1996-02-09 | 1998-06-02 | The Procter & Gamble Company | Photoprotective compositions |
| KR100581374B1 (en) * | 1999-04-22 | 2006-05-24 | 주식회사 엘지생활건강 | Cosmetic composition having an effect on improving dull skin color |
| GB9918023D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
| JP2002356414A (en) * | 2001-05-29 | 2002-12-13 | Hayashibara Biochem Lab Inc | Whitening agent |
| JP2005068159A (en) * | 2004-11-01 | 2005-03-17 | Kao Corp | Gray hair prevention agent |
| KR100982435B1 (en) | 2008-02-25 | 2010-09-15 | 인하대학교 산학협력단 | (2Z , 8Z) —Skin whitening composition containing Matricaric acid methyl ester as an active ingredient |
| JP2011068576A (en) * | 2009-09-24 | 2011-04-07 | Pola Chemical Industries Inc | External preparation for skin whitening |
-
1990
- 1990-05-22 JP JP2131988A patent/JP2881333B2/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101256180B1 (en) * | 2011-07-25 | 2013-04-19 | 동의대학교 산학협력단 | Cosmetic composition comprising extract of thin film outer cover of Luffa Roemer seed for skin whitening |
| KR20210023155A (en) * | 2019-08-22 | 2021-03-04 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
| KR102294967B1 (en) * | 2019-08-22 | 2021-08-30 | 이중회 | Cosmetic composition comprising luffa cylindrica sap as active ingredient |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0426610A (en) | 1992-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940000671B1 (en) | Compositions for topical use having melanin synthesis-inhibiting activity | |
| AU2002334601B2 (en) | Anti-irritating rosacea treatment | |
| US20110065794A1 (en) | Wrinkle-preventing and improving composition | |
| JP2881333B2 (en) | Whitening cosmetics | |
| JPH06321752A (en) | Whitening agent | |
| JPH01186809A (en) | Skin beautifying cosmetic | |
| JPH0567125B2 (en) | ||
| JPH09291021A (en) | Beautifying and whitening cosmetic | |
| JP2676049B2 (en) | Skin cosmetics | |
| JP2534191B2 (en) | Whitening agent | |
| JP2002226318A (en) | Combination of active ingredients of citrate ester having surface activity and α-lipoic acid and cosmetic and dermatological preparations containing the mixture | |
| JPH0725660B2 (en) | Cosmetics with anti-inflammatory properties against sunburn | |
| JPH05201847A (en) | Skin-beautifying cosmetic | |
| JPH06128136A (en) | Skin external preparation | |
| JPH01283208A (en) | Beautifying cosmetic | |
| KR100347976B1 (en) | Composition for topical application to the skin and/or its superficial body growths, comprising at least one compound comprising a phenyloxime ftagment | |
| JP2001172173A (en) | Cosmetic composition containing N-ethyloxycarbonyl-4-aminophenol and arbutin or a derivative thereof and / or ellagic acid or a derivative thereof | |
| JP3170024B2 (en) | Whitening cosmetics | |
| JPH08245359A (en) | Photo-aging resister and skin cosmetic containing the resister | |
| JPH072640A (en) | External preparation for protecting ultraviolet disorder | |
| JPH06172150A (en) | Skin cosmetics | |
| JP2002128654A (en) | Skin care preparation | |
| JP3447791B2 (en) | Whitening agent | |
| JP2720247B2 (en) | External preparation for skin | |
| JP4889069B2 (en) | Moisturizer, whitening agent and skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090205 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090205 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100205 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |